# A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects

> **NCT00896558** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 52 (actual)

## Conditions studied

- Infections, Bacterial

## Interventions

- **DRUG:** GSK1322322/placebo
- **DRUG:** GSK1322322/placebo and midazolam

## Key facts

- **NCT ID:** NCT00896558
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05-11
- **Primary completion:** 2009-09-25
- **Final completion:** 2009-09-25
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2017-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00896558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00896558, "A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00896558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*